Jan 2016 21 Philogen S.p.A announced the launch of a pivotal trial in patients with Stage IIIB/C melanoma
Jan 2016 21 Philogen S.p.A. announced that Pfizer Inc. (NYSE: PFE) has exercised options granted under the agreement established in December 2014